Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1216 AL 1230

Proposing a Parkinson's disease-specific tremor scale from the MDS-UPDRS

Forjaz MJ, Ayala A, Testa CM, Bain PG, Elble R, Haubenberger D, Rodriguez-Blazquez C, Deuschl G, Martinez-Martin P; International Parkinson and Movement Disorder Society Tremor Rating Scale Task Force.

Mov Disord. 2015 Jul;30(8):1139-43. doi: 10.1002/mds.26271. Epub 2015 Jun 11.

Gaucher disease and comorbidities: B-cell malignancy and parkinsonism

Cox TM, Rosenbloom BE, Barker RA.

Am J Hematol. 2015 Jul;90 Suppl 1:S25-8. doi: 10.1002/ajh.24057.

Multidisciplinary rehabilitation in Parkinson's disease: A milestone with future challenges

Rochester L, Espay AJ.

Mov Disord. 2015 Jul;30(8):1011-3. doi: 10.1002/mds.26277. Epub 2015 Jun 11.

Current treatment and future prospects of dopa-induced dyskinesias

Mazzucchi S, Frosini D, Bonuccelli U, Ceravolo R.

Drugs Today (Barc). 2015 May;51(5):315-29. doi: 10.1358/dot.2015.51.5.2313726.

Brain SPECT and MRI Findings in a Uremic Patient With Parkinsonism

Choi EK, Oh JK, Chung YA, Song IU.

Clin Nucl Med. 2015 Sep;40(9):e453-4. doi: 10.1097/RLU.0000000000000869.

Are there treatments for atypical parkinsonism? An update on actual options

Moretti DV.

Rev Neurosci. 2015;26(5):547-53. doi: 10.1515/revneuro-2015-0008.

Association of the COQ2 V393A Variant with Parkinson's Disease: A Case-Control Study and Meta-Analysis

Yang X, Xi J, Zhao Q, Jia H, An R, Liu Z, Xu Y.

PLoS One. 2015 Jun 22;10(6):e0130970. doi: 10.1371/journal.pone.0130970. eCollection 2015.

GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding

Schneider JS, Cambi F, Gollomp SM, Kuwabara H, Brašić JR, Leiby B, Sendek S, Wong DF.

J Neurol Sci. 2015 Sep 15;356(1-2):118-23. doi: 10.1016/j.jns.2015.06.028. Epub 2015 Jun 16.

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration

Van Rompuy AS, Oliveras-Salvá M, Van der Perren A, Corti O, Van den Haute C, Baekelandt V.

Mol Neurodegener. 2015 Jun 23;10:23. doi: 10.1186/s13024-015-0017-8.

Subthalamic nucleus stimulation and spontaneous language production in Parkinson's disease: A double laterality problem

Batens K, De Letter M, Raedt R, Duyck W, Vanhoutte S, Van Roost D, Santens P.

Brain Lang. 2015 Aug;147:76-84. doi: 10.1016/j.bandl.2015.06.002. Epub 2015 Jun 19.

Anxiety rating scales in Parkinson's disease: a critical review updating recent literature

Dissanayaka NN, Torbey E, Pachana NA.

Int Psychogeriatr. 2015 Nov;27(11):1777-84. doi: 10.1017/S1041610215000885. Epub 2015 Jun 23.

Is early-life iron exposure critical in neurodegeneration?

Hare DJ, Arora M, Jenkins NL, Finkelstein DI, Doble PA, Bush AI.

Nat Rev Neurol. 2015 Sep;11(9):536-44. doi: 10.1038/nrneurol.2015.100. Epub 2015 Jun 23.

BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: study protocol for a randomized controlled trial

Ghielen I, van den Heuvel OA, de Goede CJ, Houniet-de Gier M, Collette EH, Burgers-Bots IA, Rutten S, Kwakkel G, Vermunt K, van Vliet B, Berendse HW, van Wegen EE.

Trials. 2015 Jun 23;16:283. doi: 10.1186/s13063-015-0804-0.

Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease

Kumaran R, Cookson MR.

Hum Mol Genet. 2015 Oct 15;24(R1):R32-44. doi: 10.1093/hmg/ddv236. Epub 2015 Jun 22.

Novel Therapeutic GPCRs for Psychiatric Disorders

Komatsu H.

Int J Mol Sci. 2015 Jun 19;16(6):14109-21. doi: 10.3390/ijms160614109.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias